"Apocrine Glands" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Large, branched, specialized sweat glands that empty into the upper portion of a HAIR FOLLICLE instead of directly onto the SKIN.
Descriptor ID |
D001050
|
MeSH Number(s) |
A10.336.899.206 A17.815.830.206
|
Concept/Terms |
Apocrine Glands- Apocrine Glands
- Apocrine Gland
- Gland, Apocrine
- Glands, Apocrine
|
Below are MeSH descriptors whose meaning is more general than "Apocrine Glands".
Below are MeSH descriptors whose meaning is more specific than "Apocrine Glands".
This graph shows the total number of publications written about "Apocrine Glands" by people in this website by year, and whether "Apocrine Glands" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Apocrine Glands" by people in Profiles.
-
An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast. Clin Breast Cancer. 2022 06; 22(4):e576-e585.
-
Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast. Hum Pathol. 2015 Sep; 46(9):1350-9.
-
Apocrine carcinoma of the breast: a comprehensive review. Histol Histopathol. 2013 11; 28(11):1393-409.
-
IMP3, a proposed novel basal phenotype marker, is commonly overexpressed in adenoid cystic carcinomas but not in apocrine carcinomas of the breast. Appl Immunohistochem Mol Morphol. 2011 Oct; 19(5):413-6.
-
Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor. Am J Clin Pathol. 2000 Apr; 113(4):572-5.
-
Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Pathol Res Pract. 1997; 193(11-12):753-8.